Catalyst Wire Dossier Catalyst Wire Dossier

Tc99m-Maraciclatide

Maraciclatide · GE Healthcare
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tc99m-Maraciclatide, covering 2014-02-04 to 2014-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction [Phase 2]

See pricing